<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Molecular Cancer Biology Program on Michael’s Domain</title><link>https://jeltsch.org/en/tags/molecular-cancer-biology-program/</link><description>Recent content in Molecular Cancer Biology Program on Michael’s Domain</description><generator>Hugo</generator><language>en-us</language><copyright>Copyright © 2002 - 2026 Michael Jeltsch.</copyright><lastBuildDate>Fri, 24 Jul 2026 00:18:18 +0300</lastBuildDate><atom:link href="https://jeltsch.org/en/tags/molecular-cancer-biology-program/index.xml" rel="self" type="application/rss+xml"/><item><title>Äkta Explorer FPLC core facility</title><link>https://jeltsch.org/en/akta_explorer_fplc_core_facility/</link><pubDate>Wed, 26 Jan 2011 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/akta_explorer_fplc_core_facility/</guid><description>&lt;p&gt;Nowadays I spend much of my time at work on the purification of proteins which regulate 
 &lt;a href="http://www.nature.com/nature/supplements/insights/angiogenesis/index.html" target="_blank" rel="noopener noreferrer nofollow"&gt;angiogenesis and lymphangiogenesis&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. Therefore, I am taking care of the necessary machinery that the 
 &lt;a href="http://research.med.helsinki.fi/cancerbio/infra.htm" target="_blank" rel="noopener noreferrer nofollow"&gt;Molecular Cancer Biology Research Program&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 owns: the fast protein liquid chromatography (FPLC) machine.
 &lt;a href="http://research.med.helsinki.fi/cancerbio/keski-oja/group.htm" target="_blank" rel="noopener noreferrer nofollow"&gt;Prof. Jorma Keski-Oja&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 acquired about 15 years ago one of the first (and in 2010 discontinued) Äkta Explorer machines from Swedish producer 
 &lt;a href="http://en.wikipedia.org/wiki/Pharmacia" target="_blank" rel="noopener noreferrer nofollow"&gt;Pharmacia&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 (who merged in 1997 with 
 &lt;a href="http://en.wikipedia.org/wiki/Amersham_plc" target="_blank" rel="noopener noreferrer nofollow"&gt;Amersham&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 to become Amersham Pharmacia Biotech, who was in turn bought by 
 &lt;a href="http://www.gehealthcare.com" target="_blank" rel="noopener noreferrer nofollow"&gt;GE Healthcare&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 in 2004). In the year 2000 the equipment moved from the 
 &lt;a href="http://www.hi.helsinki.fi/hi/res/res.html" target="_blank" rel="noopener noreferrer nofollow"&gt;Haartman Institute&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 into the 
 &lt;a href="http://www.biomedicum.fi" target="_blank" rel="noopener noreferrer nofollow"&gt;Biomedicum Helsinki&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. While I have maintained web pages for this piece of research infrastructure for the last five years (including online reservation and data backup), they were only available from inside the 
 &lt;a href="http://www.helsinki.fi/university" target="_blank" rel="noopener noreferrer nofollow"&gt;Helsinki University&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 network.Now, I managed to have 
 &lt;a href="http://research.med.helsinki.fi/corefacilities/akta/index.html" target="_blank" rel="noopener noreferrer nofollow"&gt;web pages about the Äkta Explorer FPLC core facility&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 added to the web site of the 
 &lt;a href="http://www.med.helsinki.fi/english/" target="_blank" rel="noopener noreferrer nofollow"&gt;Medical Faculty&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. At the moment, we are adding the 
 &lt;a href="http://www.gelifesciences.com/aptrix/upp01077.nsf/content/wave_bioreactor_home" target="_blank" rel="noopener noreferrer nofollow"&gt;WAVE cell culture system&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 to our facility to be able to produce large amounts of cells/cell culture supernatant (up to 25 liters of bacterial, insect or mammalian cell culture) for protein production.&lt;/p&gt;</description></item><item><title>Growth factor regulation of lymphangiogenesis</title><link>https://jeltsch.org/en/growth_factor_regulation_of_lymphangiogenesis/</link><pubDate>Sun, 06 Aug 2006 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/growth_factor_regulation_of_lymphangiogenesis/</guid><description>&lt;p&gt;All cells in our body need oxygen and they receive it via the circulating blood. That&amp;rsquo;s why the vascular system is the first organ system to function in a developing embryo. Before the heart starts pumping, the embryo&amp;rsquo;s need for oxygen has to be met by diffusion alone. But diffusion is sufficient only until the embryo reaches a size of several millimetres. Tumours face the same problem, when reaching a similar size. Both the developing embryo and the solid tumor can only continue growing if they manage to establish a circulatory system that supplies them with oxygen and nutrients. While cancer depends on the pathological growth of blood vessels, other diseases are caused by insufficient vascular function. E.g. in cardiovascular disease the blood vessels cannot deliver enough oxygen to the heart muscle. Apart from the cardiovascular system there is another vascular system: the lymphatic system. It functions mainly in tissue drainage and immune defense against pathogens. Similar to the cardiovascular function, the lymphatic system plays an important role in several diseases. E.g. in lymphedema patients suffer from swollen limbs because lymphatic vessels are absent or not functioning properly. And the spread of cancer (&amp;ldquo;metastasis&amp;rdquo;) seems to be intimately related to the lymphatic system as the cancer cells use the lymphatic vessels as pathways to travel within the body.&lt;/p&gt;</description></item></channel></rss>